N🟁N

Market Maker Surveillance Report. RENT, ROSG, ANTH, DVOX, AMPE, CVV, Winning Stocks With Lowest Price Friction For Tuesday, Au

August 23, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3686 companies with "abnormal" market making, 4942 companies with positive Friction Factors and 2006 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. RENTRAK CORP (NASDAQ:RENT), ROSETTA GENOMICS LTD (NASDAQ:ROSG), ANTHERA PHARMACEUTICALS INC (NASDAQ:ANTH), DYNAVOX INC-CLASS A (NASDAQ:DVOX), AMPIO PHARMACEUTICALS INC (OTC:AMPE), CVD EQUIPMENT CORP (NASDAQ:CVV). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     RENT       $2.760       23.96%       55,435          60.79%       35,458          38.88%       19,977          72      
     ROSG       $0.210       18.47%       38,008          51.15%       36,296          48.85%       1,712           82      
     ANTH       $1.110       22.24%       103,761         66.12%       53,056          33.81%       50,705          457     
     DVOX       $0.940       18.88%       34,711          53.62%       29,624          45.76%       5,087           54      
     AMPE       $1.860       36.05%       83,192          65.11%       38,894          30.44%       44,298          238     
     CVV        $2.610       20.52%       149,257         58.23%       101,778         39.71%       47,479          182     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows RENT with a dollar gain Tuesday of $2.76000 and a Friction Factor of 72 shares. That means that it only took 72 more shares of buying than selling to move RENT higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

RENTRAK CORP (NASDAQ:RENT) - Rentrak Corporation, an information management company, provides content measurement and analytical services to companies in the entertainment industry. The company delivers content performance data for various entertainment platforms and media technologies, including television, theatrical, home entertainment, mobile, and broadband video. It operates in two divisions, Home Entertainment, and Advanced Media and Information. The Home Entertainment division delivers home entertainment content products, such as DVDs and blue-ray discs; and offers related rental and sales information for the content to home video specialty stores and other retailers in the United States and Canada. It leases products from various suppliers, including motion picture studios; and retailers sublease and rent these products to consumers. This division also includes direct revenue sharing (DRS) services, which encompasses the collection, tracking, auditing, and reporting of transaction and revenue data generated by DRS retailers to its respective DRS clients. The AMI division offers Essentials Suite of business information services. This divisions Essentials Suite software and services provide data collection, management, analysis, and reporting functions. It also collects and process data from across 26 countries. This division has operations in California, New York, Florida, the United Kingdom, Australia, Germany, France, Mexico, Argentina, Spain, and Russia. The company was founded in 1977 and is headquartered in Portland, Oregon with additional offices in Los Angeles, New York City, Miami/Ft. Lauderdale, Argentina, Australia, France, Germany, Mexico, Spain, and the United Kingdom.

ROSETTA GENOMICS LTD (NASDAQ:ROSG) - Rosetta Genomics Ltd. develops microRNA-based diagnostic and in Israel. MicroRNAs are naturally expressed, or produced, using instructions encoded in deoxyribonucleic acid and are used in regulating protein production. The company develops microRNA-based diagnostic programs for various cancers, as well as for the identification of the origin of the primary tumor of metastases; for differentiating squamous from non squamous non-small cell lung cancer; and for differentiating mesothelioma from other carcinomas in the lung and pleura. The company also focuses on the development of body fluid-based diagnostic tests. In addition, it develops microRNA-based therapeutic products for the treatment of liver cancer. The company has a license and collaboration agreement with Prometheus Laboratories Inc. to license and sublicense certain rights related to the companys microRNA-based cancer diagnostic tests; and a collaboration agreement with CBR Institute for Biomedical Research to study the role of microRNAs in hematopoeisis. Rosetta Genomics Ltd. was founded in 2000 and is based in Rehovot, Israel.

ANTHERA PHARMACEUTICALS INC (NASDAQ:ANTH) - Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome associated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.

DYNAVOX INC-CLASS A (NASDAQ:DVOX) - DynaVox Inc. designs, manufactures, and distributes electronic and symbol-based augmentative communication equipment, software, and services. It offers speech generating technology and special education software solutions for individuals with speech, language, physical, or learning disabilities. The companys speech generating technology solutions include DynaVox V and Vmax, a Series V product line of speech generating devices; EyeMax system comprising Vmax and EyeMax accessory that allows users to control the Vmax with a blink or by causing the eye to dwell on a desired area of the screen; portable Xpress speech generating device; Tango, a speech generating device designed for children and young adults; M3, a digitized-only device that plays back pre-recorded messages; and DynaWrite, a communication device for two-handed typists. Its special education software solutions consist of Boardmaker Plus! for talking and playing sound recordings and movies; and creating talking activity boards, worksheets, schedules, books, writing activities, and games, as well as include Boardmaker, an education software platform used by educators and speech language pathologists for creating printed symbol-based communication and education materials for students with learning challenges. The company also provides a library of content to educators; and hosts and manages AdaptedLearning.com, which offers users of its special education software platform with an online community. DynaVox Inc. distributes its speech generating devices through a direct sales force in the United States, Canada, and the United Kingdom; and through strategic partnerships with third-party distributors internationally, as well as sells its special education software through direct mail, Internet, and catalog. The company was founded in 1983 and is headquartered in Pittsburgh, Pennsylvania.

AMPIO PHARMACEUTICALS INC (OTC:AMPE) - Ampio Pharmaceuticals, Inc. discovers and develops drugs for metabolic, eye, kidney, inflammation, and central nervous system diseases. The companys principal products include Optina, an oral drug that is in Phase II clinical trials for the treatment of diabetic retinopathy and macular edema; and Vasaloc, an oral drug in Phase II clinical trials for the treatment of diabetic nephropathy. It is also developing DMI-9523, a new molecular entity being developed as a non-steroidal oral drug for the treatment of diseases involving inflammation. Ampio Pharmaceuticals, Inc. was formerly known as DMI Life Sciences, Inc. and changed its name to Ampio Pharmaceuticals, Inc. in March 2010. Ampio Pharmaceuticals, Inc. was founded in 1990 and is based in Greenwood Village, Colorado.

CVD EQUIPMENT CORP (NASDAQ:CVV) - CVD Equipment Corporation designs, develops, and manufactures equipment and process solutions used to develop and manufacture advanced solar, nano electronic components, materials, and coatings for research and industrial applications in the United States and internationally. Its CVD/First Nano division supplies chemical vapor deposition systems for use in the research, development, and manufacture of semiconductors, LEDs, carbon nanotubes, nanowires, solar cells, and various industrial applications. The companys Stainless Design Concept division designs and manufactures gas and chemical delivery control systems for semiconductor fabrication processes, solar cells, LEDs, carbon nanotubes, nanowires, and various industrial applications. CVD Equipment Corporations Conceptronic division engages in the design and manufacture of reflow ovens and rework stations for the printed circuit board assembly and semi-conductor packaging industries. This division also offers customized products for complex heating and drying applications. CVD Equipment Corporation also offers rapid thermal processing systems for implant activation, oxidation, silicide formation, and other processes; provides annealing and diffusion furnaces for diffusion, oxidation, implant anneal, solder reflow, solar cell manufacturing, and other processes; and offers fabricated quartz ware used in its equipment and other customer tools, as well as provides repair and replacement of quartz wares. The company sells its products primarily to electronic component manufacturers; institutions involved in electronic component research comprising universities, government, and industrial laboratories; and aerospace and other industries. CVD Equipment Corporation markets it products directly, as well as through a network of domestic and international sale representatives, and distributors. The company was founded in 1982 and is headquartered in Ronkonkoma, New York.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net